Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Check here for more information about www.novartis.com
Boehringer Ingelheim has over 95 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
Check here for more information about www.boehringer-ingelheim.com
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
Check here for more information about www.sanofi.com
Driven by innovative science and an entrepreneurial culture, AstraZeneca is focused on the delivery of life-changing medicines that are fuelling growth and contributing value to patients and society.
Check here for more information about www.astrazeneca.com
CSL Behring’s portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.
Check here for more information about www.cslbehring.com
